Spurious elevation of the cerebrospinous fluid white cell counts in three patients receiving liposomal cytarabine as part of post-remission therapy.
R
R
Swords
C
C
O'Rafferty
F
F
Giles
P
P
Browne
D000328:Adult; D000964:Antimetabolites, Antineoplastic / Q000008:administration & dosage*; D002051:Burkitt Lymphoma / Q000134:cerebrospinal fluid / Q000188:drug therapy* / Q000276:immunology*; D002555:Cerebrospinal Fluid / Q000166:cytology*; D003561:Cytarabine / Q000008:administration & dosage*; D005260:Female; D006801:Humans; D015470:Leukemia, Myeloid, Acute / Q000134:cerebrospinal fluid / Q000188:drug therapy / Q000276:immunology; D007958:Leukocyte Count / Q000592:standards*; D008081:Liposomes / Q000008:administration & dosage / Q000134:cerebrospinal fluid; D008297:Male; D008875:Middle Aged; D012074:Remission Induction; D015203:Reproducibility of Results
D000964:Antimetabolites, Antineoplastic; D008081:Liposomes; D003561:Cytarabine